ranimustine has been researched along with Leukemia L 1210 in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujimoto, S; Ogawa, M | 1 |
| Kato, T; Ota, K | 2 |
| Araki, T; Kinbara, M; Ninomiya, K; Sekido, S; Ueno, M | 1 |
| Araki, T; Ninomiya, K; Sekido, S | 1 |
| Fujimoto, S; Ogawa, M; Tashiro, T | 1 |
| Oguro, M; Takenaga, K; Yanagawa, T | 1 |
| Iwasaki, M; Ninomiya, K; Sekido, S | 1 |
| Hoshino, A; Ito, Y; Machida, S | 1 |
9 other study(ies) available for ranimustine and Leukemia L 1210
| Article | Year |
|---|---|
A new nitrosourea derivative TA-077, 1-(2-chloroethyl)-3-isobutyl-3-(beta-maltosyl)-1-nitrosourea. I. Comparative study on antitumor activity.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Drug Administration Schedule; Female; Humans; Leukemia L1210; Leukemia P388; Lung Neoplasms; Male; Melanoma; Mice; Mice, Inbred C57BL; Mice, Nude; Neoplasm Transplantation; Neoplasms, Experimental; Nimustine; Nitrosourea Compounds; Streptozocin | 1982 |
[Comparative effect of administration schedules on the antitumor activities of 3 water-soluble nitrosoureas, ACNU, GANU and MCNU against L1210 leukemia].
Topics: Animals; Antineoplastic Agents; Drug Administration Schedule; Leukemia L1210; Mice; Nimustine; Nitrosourea Compounds; Solubility; Streptozocin | 1983 |
[Experimental studies on oral administration of nitrosourea anti-tumor agent, MCNU].
Topics: Administration, Oral; Animals; Antineoplastic Agents; Dogs; Female; Half-Life; Leukemia L1210; Liver Neoplasms, Experimental; Lung Neoplasms; Male; Mice; Mice, Inbred C57BL; Neoplasms, Experimental; Nitrosourea Compounds; Streptozocin | 1984 |
[Effect of combination chemotherapy of nitrosourea MCNU with various anti-tumor agents].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carbazilquinone; Cell Line; Cyclophosphamide; Cytarabine; Doxorubicin; Female; Fluorouracil; Leukemia L1210; Lung Neoplasms; Melanoma; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Mitomycin; Mitomycins; Nitrosourea Compounds | 1984 |
Antitumor activity and toxicity of methyl 6-[3-(2-chloroethyl)- 3-nitrosoureido]-6-deoxy-alpha-D-glucopyranoside in experimental animals.
Topics: Animals; Antineoplastic Agents; Cell Line; Leukemia L1210; Leukemia P388; Lung Neoplasms; Melanoma; Mice; Neoplasms, Experimental; Nitrosourea Compounds; Structure-Activity Relationship; Tumor Stem Cell Assay; Urinary Bladder Neoplasms | 1984 |
[Antitumor activity of a new nitrosourea, MCNU, on a cellular morphological basis evaluated by a new in vitro antitumor sensitivity assay].
Topics: Animals; Antineoplastic Agents; Carmustine; Cell Survival; Dose-Response Relationship, Drug; Drug Resistance; Humans; In Vitro Techniques; Leukemia L1210; Lomustine; Nimustine; Nitrosourea Compounds; Semustine; Tumor Stem Cell Assay | 1984 |
Biologic activity of MCNU: a new antitumor agent.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Bone Marrow; Female; Leukemia L1210; Lung Neoplasms; Male; Melanoma; Mice; Mice, Inbred Strains; Neoplasms, Experimental; Nitrosourea Compounds; Sarcoma, Experimental | 1979 |
[Effects of derivatives of Ara-C, 5-fluorouracil and nitrosourea against intracerebral implanted L1210 leukemia].
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Blood-Brain Barrier; Brain Neoplasms; Cytarabine; Fluorouracil; Leukemia L1210; Mice; Neoplasm Transplantation; Nimustine; Nitrosourea Compounds; Streptozocin; Tegafur; Uracil | 1987 |
[Effects of combination chemotherapy of MCNU with various anti-cancer agents].
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Doxorubicin; Female; Fluorouracil; Leukemia L1210; Leukemia P388; Leukemia, Experimental; Mercaptopurine; Methotrexate; Mice; Mice, Inbred DBA; Mitomycin; Mitomycins; Nitrosourea Compounds; Thioguanine | 1985 |